Test ID LBOR0247 HLA-B*57:01 Genotype, Pharmacogenomics, Varies
Useful For
Identifying individuals with an increased risk of hypersensitivity reactions to abacavir, based on the presence of the human leukocyte antigen HLA-B*57:01 allele
Identifying individuals taking pazopanib who have an increased risk of elevated alanine aminotransferase levels based of the presence of the human leukocyte antigen HLA-B*57:01 allele
Specimen Type
VariesSpecimen Required
Multiple genotype tests can be performed on a single specimen after a single extraction. See Multiple Genotype Test List for a list of tests that can be ordered together.
Submit only 1 of the following specimens:
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA)
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in original tube. Do not aliquot.
Specimen Stability Information: Ambient (preferred) 9 days/Refrigerated 30 days
Specimen Type: Saliva
Supplies: Saliva Swab Collection Kit (T786)
Patient Preparation: Patient should not eat, drink, smoke, or chew gum 30 minutes prior to collection.
Specimen Volume: 1 Swab
Collection Instructions: Collect and send specimen per kit instructions.
Specimen Stability Information: Ambient 30 days
Specimen Type: Extracted DNA
Container/Tube: 2 mL screw top tube
Specimen Volume: 100 mcL (microliters)
Collection Instructions:
1. The preferred volume is 100 mcL at a concentration of 50 ng/mcL.
2. Include concentration and volume on tube.
Specimen Stability Information: Frozen (preferred) 1 year/Ambient/Refrigerated
Specimen Minimum Volume
Blood: 0.4 mL
Saliva: 1 swab
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Varies |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Special Instructions
Day(s) Performed
Monday, Wednesday through Friday
Report Available
3 to 7 daysMethod Name
Qualitative Allele-Specific Real-Time Polymerase Chain Reaction (PCR)
Reporting Name
HLA-B 5701 Genotype, VPerforming Laboratory
Mayo Clinic Laboratories in RochesterSecondary ID
610054CPT Code Information
81381
Reference Values
Negative
An interpretive report will be provided.
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Testing Algorithm
See Abacavir Hypersensitivity Testing and Initial Patient Management Algorithm
For additional information regarding pharmacogenomic genes and their associated drugs, see the Pharmacogenomic Associations Tables
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing-Spanish (T826)
2. If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
SANFORD LABORATORY INTERFACE BUILD INFORMATION
Result Code | Result Code Description |
---|---|
28152 | HLA-B*57:01 Genotype |
28153 | HLA-B*57:01 Phenotype |
28154 | Interpretation |
28155 | Additional Information |
28156 | Method |
28157 | Disclaimer |
28158 | Reviewed By |